Evaluation of Fanconi Anemia Genes in Familial Breast Cancer Predisposition

Sheila Seal, Rita Barfoot, Hiran Jayatilake, Paula Smith, Anthony Renwick, Linda Bascombe, Lesley McGuffog, D. Gareth Evans, Diana Eccles, Douglas F. Easton, Michael R. Stratton, Nazneen Rahman

Research output: Contribution to journalArticlepeer-review


Fanconi Anemia (FA) is an autosomal recessive syndrome characterized by congenital abnormalities, progressive bone marrow failure, and susceptibility to cancer. FA has eight known complementation groups and is caused by mutations in at least seven genes. Biallelic BRCA2 mutations were shown recently to cause FA-D1. Monoallelic (heterozygous) BRCA2 mutations confer a high risk of breast cancer and are a major cause of familial breast cancer. To investigate whether heterozygous variants in other FA genes are high penetrance breast cancer Susceptibility alleles, we screened germ-line DNA from 88 BRCA1/2-negative families, each with at least three cases of breast cancer, for mutations in FANCA, FANCC, FANCD2, FANCE, FANCF, and FANCG. Sixty-nine sequence variants were identified of which 25 were exonic. None of the exonic variants resulted in translational frameshifts or nonsense codons and 14 were polymorphisms documented previously. Of the remaining 11 exonic variants, 2 resulted in synonymous changes, and 7 were present in controls. Only 2 conservative missense variants, 1 in FANCA and 1 in FANCE, were each found in a single family and were not present in 300 controls. The results indicate that FA gene mutations, other than in BRCA2, are unlikely to be a frequent cause of highly penetrant breast cancer predisposition.

Original languageEnglish
Pages (from-to)8596-8599
Number of pages4
JournalCancer Research
Issue number24
Publication statusPublished - 15 Dec 2003


Dive into the research topics of 'Evaluation of Fanconi Anemia Genes in Familial Breast Cancer Predisposition'. Together they form a unique fingerprint.

Cite this